Parkinson’s disease
Parkinson's disease: the second most common neurodegenerative disease worldwide
Parkinson's is a progressive disease that mainly affects certain functions, such as the control of movements and balance. Due to the ageing of the population and diseases connected with this phenomenon, a global increase in the number of people suffering from Parkinson's disease is expected.
The number of people living with Parkinson’s disease in the UK
The number of new diagnoses of Parkinson’s disease in people aged 45 years and above
The lifetime risk of being diagnosed with Parkinson’s disease
Zambon continues to invest in the field of Parkinson’s Disease
We started investing in the central nervous system in 2015, focusing our efforts on research into Parkinson’s disease. We continually strive to seek solutions in this sector with patients at the core of what we do.